In this issue:
Synthetic cannabinoid-associated coagulopathy outbreak in the US
Effect of aspirin on CV events/ bleeding in the healthy elderly
Do the benefits of aspirin for primary prevention exceed the bleeding risk?
Ruxolitinib + azacitidine for myelofibrosis
Validation of prognostic thrombosis models for essential thrombocythaemia
VTE recurrence risk among Danes
VTE recurrence risk according to baseline risk factor profiles
Aspirin vs. other anticoagulants for VTE prevention after TKA
Alcohol consumption does not increase PE risk
ATE frequency, risk factors and impact on mortality in cancer
Please login below to download this issue (PDF)